Canadian eyewear retailer Kits Eyecare's Q3 revenue rises 25%

Kits Eyecare

06/11/2025 21:09

Overview

Kits Eyecare Q3 revenue rises 25.1% yr/yr to all-time high of C$52.4 mln

Adjusted EBITDA for Q3 improves 79% to C$2.9 mln

Net income for Q3 surges to C$1.9 mln, up 1,367.4% yr/yr

Outlook

Kits Eyecare expects Q4 2025 revenue between C$52 mln and C$54 mln

Company anticipates Q4 2025 adjusted EBITDA margin between 4% and 6%

Kits Eyecare plans to announce a Chief Marketing Officer in Q1 2026

Result Drivers

STRATEGIC PRICING - Margin expansion driven by strategic pricing, improved product mix, and targeted promotions

CUSTOMER GROWTH - Active customers surpassed 1 million, increasing 15.7% yr/yr

DISCIPLINED EXECUTION - Profitability driven by disciplined execution in pricing, marketing, and fulfillment

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q3 EPS
C$0.06
Q3 Net Income
C$1.90 mln
Q3 EBITDA
C$3.30 mln
Q3 Gross Profit
C$18.10 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

The average consensus recommendation for the miscellaneous specialty retailers peer group is "buy"

Wall Street's median 12-month price target for Kits Eyecare Ltd is C$23.00, about 42.7% above its November 5 closing price of C$13.18

The stock recently traded at 47 times the next 12-month earnings vs. a P/E of 72 three months ago

Press Release: ID:nCNWvVJ3La

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)